← All partners Partner
Cedars-Sinai Medical Center.
The technology behind LUCY was invented at Cedars-Sinai, validated there, and is licensed exclusively to BlackLight. The hospital is both a clinical partner and a shareholder.
Cedars-Sinai Medical Center
- U.S. News & World Report “Best Hospitals” Honor Roll for the 10th consecutive year; #1 in California.
- Ranked #9 nationally in total NIH funding among independent hospitals.
- Exclusively licensed its technologies to BlackLight and actively supports the company as a shareholder.
- Dr. Keith Black champions the collaboration with BlackLight across numerous Cedars-Sinai disciplines.
Contributions to BlackLight
- 1 Ideation
Original invention source for BlackLight technologies.
- 2 Validation
Cedars-Sinai conducted the initial validation studies.
- 3 Publication
A continuous wave of peer-reviewed papers forthcoming.
- 4 Adoption
Will lead the roll-out of BlackLight innovations into real-world clinical use.
Cedars Fluorescence Imaging Lab
- Technology insights: a reliable source of the latest research ideas for BlackLight.
- Joint R&D: a close collaborator for joint research and development projects.
- IP ownership: BlackLight funds certain personnel at the Cedars Fluorescence Imaging Lab, and therefore owns the IP arising from such sponsored work.